Development of a Risk Model Predicting Chemotherapy-induced Grade 3-4 Neutropenia by Paclitaxel/Carboplatin in Epithelial Ovarian Cancer: Prospective Observational Study for Model Development and Retrospective Study for Validation of Developed Model
Observational Model: Cohort, Time Perspective: Prospective
Risk prediction model for grade 3-4 chemotherapy induced neutropenia
Jeong-Yeol Park, M.D., Ph.D.
Asan Medical Center
Korea: Asan Medical Center Institutional Review Board